Company intelligence / Profile preview

Velano Vascular

San Francisco, California, United Statesbd.com ↗

Ownership: Private
Development stage: Commercial

Overview

Velano Vascular developed the FDA-cleared PIVO™ needle-free blood draw device, which enables high-quality blood samples to be drawn through existing peripheral IV catheters. The technology has been adopted by dozens of U.S. hospitals and has enabled millions of procedures, reducing unnecessary needle sticks and improving patient care. The company received multiple industry accolades for innovation prior to its acquisition.

Therapeutic areas: Hematology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

Intermountain Healthcare (early adopter/investor)Griffin Hospital, The Children’s Hospital of Philadelphia (investors/pilot sites)

Beyond the preview

Go deeper on Velano Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Velano Vascular.

Explore the full profile